Endothelial Function (Reactive Hyperemia)

4

Review clinical trials related to Endothelial Function (Reactive Hyperemia). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Peanuts for Cardiometabolic, Brain, and Intestinal Health

The overall objective of this 14-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improve cardiometabolic, cognitive, and intestinal health in a racially diverse prediabetes population.

Participants needed: 72
Trial details
Age: 20-59Biological sex: AllType: InterventionalSponsor: Georgia State UniversityUpdated: Mar 27, 2026Locations: 1
Eligibility criteria

men and women [+4]

Allergies to peanuts and peanut products [+9]

Status: Recruiting

Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure

The purpose of the study is to determine the effectiveness of wild blueberries on cardiovascular health, cognitive function, and gut microbiota composition in non-Hispanic Black and White adults with elevated blood pressure.

Participants needed: 40
Trial details
Age: 45-65Biological sex: AllType: InterventionalSponsor: Georgia State UniversityUpdated: Mar 27, 2026Locations: 1
Eligibility criteria

Individuals 45-65 years of age [+3]

Allergies to berries [+7]

Status: Recruiting

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

The goal of this clinical trial is to determine the effectiveness of using a freeze-dried wild blueberry powder on cardiometabolic health, cognitive function, and gut microbiota composition in adult women with prediabetes.

Participants needed: 30
Trial details
Age: 20-65Biological sex: FemaleType: InterventionalSponsor: Georgia State UniversityUpdated: Mar 25, 2026Locations: 1
Eligibility criteria

Women aged 20-65 years old [+2]

Allergies to berries [+8]

Status: Not yet recruiting

Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury

The objective of this clinical trial is to better understand how lactate, a naturally occurring energy substance, can be used to lessen damage to the vascular system in adults with a high cardiovascular disease risk. The main questions it aims to answer are: 1. Does giving lactate intravenously reduce injury to the vascular system? 2. Does giving lactate intravenously together with blood flow occlusion - known as ischemic preconditioning, reduce vascular injury better than blood flow occlusion by itself? 3. How does lactate help the vascular system? Researchers will compare lactate to a placebo (a look-alike substance that contains no lactate) to see if lactate works to lessen vascular injury. Researchers will also compare lactate to blood flow occlusion to see which one is better at preventing vascular injury. Researchers will also compare lactate and blood flow occlusion together to see if combining them works better than either one alone. In one visit to the laboratory, participants will: Obtain a measurement of vascular health in an arm Be given liquid lactate, a liquid placebo, and/or arm blood flow occlusion Obtain a second measurement of vascular health in an arm.

Participants needed: 68
Trial details
Phase: Early Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Gary Van GuilderUpdated: Feb 13, 2025Locations: 1
Eligibility criteria

Sedentary men and women between the ages of 18-65 years of all races and ethnici... [+2]

Use of medications known to affect cardiovascular function [+24]